A Seattle federal court recently dismissed a claim for attorney fees in a trade secrets case brought by a dental health insurer. The court determined the lawsuit was “objectively specious,” but concluded there wasn’t sufficient evidence to prove it was pursued “in bad faith.” This decision comes amid ongoing scrutiny of how trade secret allegations are handled in litigation.
The insurer’s case targeted two former officials, alleging breaches associated with confidential information. Despite recognizing the claims as unfounded, the court’s refusal to award fees underscores the complex nature of proving malicious intent in such cases. The ruling highlights the challenges businesses face when attempting to recoup legal costs in failed trade secret litigations.
For further details, the original Law360 article offers additional context regarding the court’s decision and its implications for similar future cases.